Already a print subscriber? Activate your online access.
Browse our complete archive of Cardiology summaries
What prophylactic dose should be recommended?
Both active drugs tested produced higher cure rates than placebo.
New risk factors have been added to the QRISK calculator.
Colonoscopy and fecal immunochemical test are first-tier screening modalities.
Weight loss and several measure of cardiovascular risk were similar in both groups.
The update addresses treatment changes for patients with either preserved or reduced systolic function.
Awareness is low, and stigma is high.
These guidelines touch upon infective endocarditis, treatment of aortic stenosis and of primary and secondary mitral regurgitation, and direct-acting oral anticoagulants, among other topics.
A new tool to support clinical decision making
New measures apply to both inpatient and outpatient settings.
Posts and discussion from NEJM Group's clinical cardiology community, active from 2009 to 2015.